WO2003076411A1 - Process for producing optically active sulfoxide derivative - Google Patents

Process for producing optically active sulfoxide derivative Download PDF

Info

Publication number
WO2003076411A1
WO2003076411A1 PCT/JP2003/002840 JP0302840W WO03076411A1 WO 2003076411 A1 WO2003076411 A1 WO 2003076411A1 JP 0302840 W JP0302840 W JP 0302840W WO 03076411 A1 WO03076411 A1 WO 03076411A1
Authority
WO
WIPO (PCT)
Prior art keywords
integer
group
optically active
represents hydrogen
sulfoxide derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2003/002840
Other languages
English (en)
French (fr)
Inventor
Hiroyuki Tawada
Tomomi Ikemoto
Atsuko Nishiguchi
Tatsuya Ito
Mari Adachi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Pharmaceutical Co Ltd
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical Co Ltd, Takeda Chemical Industries Ltd filed Critical Takeda Pharmaceutical Co Ltd
Priority to KR10-2004-7014294A priority Critical patent/KR20040091127A/ko
Priority to AU2003213454A priority patent/AU2003213454A1/en
Priority to CA002479071A priority patent/CA2479071A1/en
Priority to US10/506,955 priority patent/US20050107606A1/en
Priority to EP03708541A priority patent/EP1484322A4/en
Publication of WO2003076411A1 publication Critical patent/WO2003076411A1/ja
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/04—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D225/06—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/16—Eight-membered rings
    • C07D313/20—Eight-membered rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PCT/JP2003/002840 2002-03-12 2003-03-11 Process for producing optically active sulfoxide derivative Ceased WO2003076411A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
KR10-2004-7014294A KR20040091127A (ko) 2002-03-12 2003-03-11 광학 활성 술폭시드 유도체의 제조 방법
AU2003213454A AU2003213454A1 (en) 2002-03-12 2003-03-11 Process for producing optically active sulfoxide derivative
CA002479071A CA2479071A1 (en) 2002-03-12 2003-03-11 Process for producing optically active sulfoxide derivative
US10/506,955 US20050107606A1 (en) 2002-03-12 2003-03-11 Process for producing optically active sulfoxide derivative
EP03708541A EP1484322A4 (en) 2002-03-12 2003-03-11 PROCESS FOR PRODUCING AN OPTICALLY ACTIVE SULFOXIDE DERIVATIVE

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2002-066809 2002-03-12
JP2002066809 2002-03-12
JP2002229802 2002-08-07
JP2002-229802 2002-08-07

Publications (1)

Publication Number Publication Date
WO2003076411A1 true WO2003076411A1 (en) 2003-09-18

Family

ID=27806971

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2003/002840 Ceased WO2003076411A1 (en) 2002-03-12 2003-03-11 Process for producing optically active sulfoxide derivative

Country Status (8)

Country Link
US (1) US20050107606A1 (ja)
EP (1) EP1484322A4 (ja)
JP (1) JP2004123694A (ja)
KR (1) KR20040091127A (ja)
CN (1) CN1649847A (ja)
AU (1) AU2003213454A1 (ja)
CA (1) CA2479071A1 (ja)
WO (1) WO2003076411A1 (ja)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005116013A1 (ja) * 2004-05-28 2005-12-08 Takeda Pharmaceutical Company Limited 医薬化合物の結晶
WO2016105527A1 (en) * 2014-12-23 2016-06-30 Tobira Therapeutics, Inc. Process of making cenicriviroc and related analogs
US10045968B2 (en) 2001-08-08 2018-08-14 Tobira Therapeutics, Inc. Bicyclic compound, production and use thereof
US10301287B2 (en) 2016-08-31 2019-05-28 Tobira Therapeutics, Inc. Solid forms of cenicriviroc mesylate and processes of making solid forms of cenicriviroc mesylate
WO2019149089A1 (zh) 2018-02-02 2019-08-08 四川科伦博泰生物医药股份有限公司 含有羧酸基团的苯并氮杂环类化合物及其制备方法和用途
US10407411B2 (en) 2016-06-21 2019-09-10 Tobira Therapeutics, Inc. Purified cenicriviroc and purified intermediates for making cenicriviroc
WO2021133811A1 (en) 2019-12-26 2021-07-01 Teva Pharmaceuticals International Gmbh Solid state forms of cenicriviroc and process for preparation thereof

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004027772A1 (de) * 2004-06-08 2006-01-05 Bayer Chemicals Ag Bistropylidenamine und deren Verwendung
CA2660953A1 (en) * 2006-08-18 2008-02-21 Schering Corporation Process for resolving chiral piperidine alcohol and process for synthesis of pyrazolo [1,5-a] pyrimidine derivatives using same
US20080076120A1 (en) * 2006-09-14 2008-03-27 Millennium Pharmaceuticals, Inc. Methods for the identification, evaluation and treatment of patients having CC-Chemokine receptor 2 (CCR-2) mediated disorders
CN106957251B (zh) * 2017-04-06 2018-08-21 武汉大学 一种制备烷基硫甲基酯类化合物的方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716944A (en) * 1994-07-04 1998-02-10 Takeda Chemical Industries, Ltd. Phosphonic acid compounds, their production and use
US6096780A (en) * 1998-08-20 2000-08-01 Takeda Chemical Industries, Ltd. Quaternary ammonium salts and their use
US6166006A (en) * 1997-12-19 2000-12-26 Takeda Chemical Industries, Ltd. Anilide derivative, production and use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2625195A1 (de) * 1976-06-04 1977-12-22 Hoechst Ag 1-methyl-2-(4-aminophenyl-substit.- methyl)-5-nitro-imidazole und verfahren zu ihrer herstellung
JPS62265270A (ja) * 1986-05-13 1987-11-18 Zeria Shinyaku Kogyo Kk 新規イミダゾ−ル誘導体およびそれらを有効成分とする抗潰瘍剤
AU4145200A (en) * 1999-05-07 2000-11-21 Takeda Chemical Industries Ltd. Cyclic compounds and uses thereof
EP2206702B1 (en) * 2001-08-08 2011-12-28 Tobira Therapeutics, Inc. Bicyclic compound, production and use thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716944A (en) * 1994-07-04 1998-02-10 Takeda Chemical Industries, Ltd. Phosphonic acid compounds, their production and use
US6166006A (en) * 1997-12-19 2000-12-26 Takeda Chemical Industries, Ltd. Anilide derivative, production and use thereof
US6096780A (en) * 1998-08-20 2000-08-01 Takeda Chemical Industries, Ltd. Quaternary ammonium salts and their use

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1484322A4 *

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10045968B2 (en) 2001-08-08 2018-08-14 Tobira Therapeutics, Inc. Bicyclic compound, production and use thereof
WO2005116013A1 (ja) * 2004-05-28 2005-12-08 Takeda Pharmaceutical Company Limited 医薬化合物の結晶
WO2016105527A1 (en) * 2014-12-23 2016-06-30 Tobira Therapeutics, Inc. Process of making cenicriviroc and related analogs
US10526349B2 (en) 2014-12-23 2020-01-07 Tobira Therapeutics, Inc. Process of making cenicriviroc and related analogs
US10407411B2 (en) 2016-06-21 2019-09-10 Tobira Therapeutics, Inc. Purified cenicriviroc and purified intermediates for making cenicriviroc
US10301287B2 (en) 2016-08-31 2019-05-28 Tobira Therapeutics, Inc. Solid forms of cenicriviroc mesylate and processes of making solid forms of cenicriviroc mesylate
WO2019149089A1 (zh) 2018-02-02 2019-08-08 四川科伦博泰生物医药股份有限公司 含有羧酸基团的苯并氮杂环类化合物及其制备方法和用途
US11292785B2 (en) 2018-02-02 2022-04-05 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Nitrogen-containing benzoheterocycle compound comprising carboxylic acid group, preparation method and use thereof
WO2021133811A1 (en) 2019-12-26 2021-07-01 Teva Pharmaceuticals International Gmbh Solid state forms of cenicriviroc and process for preparation thereof

Also Published As

Publication number Publication date
CN1649847A (zh) 2005-08-03
KR20040091127A (ko) 2004-10-27
EP1484322A4 (en) 2008-01-23
EP1484322A1 (en) 2004-12-08
US20050107606A1 (en) 2005-05-19
CA2479071A1 (en) 2003-09-18
JP2004123694A (ja) 2004-04-22
AU2003213454A1 (en) 2003-09-22

Similar Documents

Publication Publication Date Title
WO2003033493A1 (en) ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR δ
PH12009501118A1 (en) Chemical compounds
AU2001252595A1 (en) Process for producing optically active sulfoxide derivative
WO2003076411A1 (en) Process for producing optically active sulfoxide derivative
NZ511311A (en) Pyrimidinylbenzimidazole and triazinylbenzimidazole derivatives useful as agricultural, horticultural bactericides
GB9711650D0 (en) Compounds useful in therapy
AU2886395A (en) 2-{1',2',4'-triazol-3'-yloxymethylene}-anilides and their use as pest-control agents
ATE238428T1 (de) Enantioselective herstellung von pharmazeutisch aktiven sulfoxiden durch bioreduktion
AU5705700A (en) Crystals of benzimidazole compounds
GEP20074210B (en) Tropane derivatives as ccr5 modulators
WO1999000373A8 (en) Benzimidazole derivatives
EP1284266A4 (en) NEW INDOIND DERIVATIVES WITH CHYME-INHIBITABLE ACTIVITIES AND METHOD FOR THEIR PREPARATION
AU6124699A (en) Aromatic amine derivatives, process for the preparation thereof and agents containing the same
KR940002249A (ko) 치환된 아미노티에노피리딘, 이의 제조방법 및 약제로서의 이의 용도
EP1555261A4 (en) VALEROLACTONE COMPOUNDS AND FRAGRANCE COMPOSITION
DE50212728D1 (de) Verfahren zur herstellung von 2-azetidinonderivaten
DE69938645D1 (de) Optisch aktive 1,4-benzodioxin-2-carbonsäure-derivate und verfahren zu ihrer herstellung
BR0009453B1 (pt) processo para a preparação de um composto.
MXPA04003086A (es) Proceso para sintesis estereoselectiva de 2-hidroximetil-cromanos.
SE0003186D0 (sv) New process
AU6531296A (en) Benzocycloalkene compounds with melatonine receptor binding affinity, their production and use
ATE123034T1 (de) Cephalosporinzwischenverbindungen, verfahren zu ihrer herstellung sowie zur herstellung ihrer endprodukte.
AU1890299A (en) Potassium channel activators
EA200200682A1 (ru) Новые соединения n-бензилпиперазина, способ их получения и фармацевтические композиции, их содержащие
DK1433480T3 (da) Lægemiddel indeholdende pyrimidin-derivat

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1279/KOLNP/2004

Country of ref document: IN

Ref document number: 01279/KOLNP/2004

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2003708541

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2479071

Country of ref document: CA

Ref document number: 1020047014294

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 1020047014294

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 20038098555

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 10506955

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2003708541

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2003708541

Country of ref document: EP